Suptavumab: A Deep Dive into the REGN2222 Monoclonal Antibody the antibody is a monoclonal protein designed to precisely inhibit IL18, a crucial cytokine associated in severe respiratory syndrome syndrome https://www.targetmol.com/compound/suptavumab